Compare GSK plc (GSK) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Altria Group Inc — how do they compare? GSK plc trades at $50.58 (market cap $102.60B), while Altria Group Inc trades at $65.04 (market cap $108.58B). The key difference: GSK plc and Altria Group Inc are close in size by market cap, and Altria Group Inc pays the higher dividend (6.52%). Which is the better fit depends on your goals.
| GSK | MO | |
|---|---|---|
Market Cap | $102.60B | $108.58B |
Sector | Health | Consumer Staples |
52-Week High | $61.18 | $74.92 |
52-Week Low | $38.22 | $54.72 |
Enterprise Value | $123.04B | $130.79B |
Dividend Yield | 3.57% | 6.52% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
